BPC-157: Preclinical Tissue-Repair Research

BPC-157 is a 15-amino-acid peptide with sequence GEPPPGKPADDAGLV that has been investigated in experimental injury systems, including a rat Achilles-tendon transection model. Study record

In rats with cysteamine-induced colitis and a colon to colon anastomosis, investigators reported improved healing of both the colitis and the surgical anastomosis after BPC-157 exposure. Study record

For distinct catalog context, not equivalent study preparations, see BPC-157 10MG.

A separate rat colocutaneous-fistula experiment assessed macroscopic and microscopic healing, biomechanics, and the water volume retained without leakage, reporting improvement with BPC-157. Study record

Following Achilles-tendon transection in rats, BPC-157-treated groups showed higher failure load and Young’s modulus, improved Achilles functional-index values, and histological changes in fibroblast and collagen formation. Study record

In rats with transected sciatic nerves, the reported improvements included axonal histomorphometry, motor action potentials, and the sciatic functional index, identifying this as a traumatic peripheral-nerve model rather than evidence for treating human neurodegenerative disease. Study record

Experiments using rat Achilles-tendon fibroblasts found increased migration and FAK/paxillin phosphorylation but no direct increase in proliferation by MTT assay, supporting a model-specific signaling observation rather than identification of a definitive peptide receptor. Study record

Taken together, these tendon, fistula, and peripheral-nerve experiments describe preclinical repair endpoints and do not establish clinical tissue-regeneration benefits in people. Study record Study record Study record

For analytical and published-literature context, see the BPC-157 and TB-500 research reference.

All materials described are for in-vitro laboratory research only and are not for human or veterinary use.